Pancreatic Cancer Research

ResearcherKumamoto Regional Medical CenterActive in the last 2 years

Naoki Umezaki

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5039564679. Sources: OpenAlex.

Their work

Papers
8
Trials
0
Grants
0
Labs led
0
Collaborators
24
Papers, trials and grants by year

2018: 4 papers · 2019: 1 paper · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 8

  1. An 8-Year Survivor after Three-Time Hepatectomies for Metachronous Pancreatic Adenocarcinoma Liver Metastases. Co-author DOI 10.70352/scrj.cr.25-0242↗
  2. High ARHGEF2 (GEF-H1) Expression is Associated with Poor Prognosis Via Cell Cycle Regulation in Patients with Pancreatic Cancer. Co-author DOI 10.1245/s10434-020-09383-9↗
  3. Postoperative nonalcoholic fatty liver disease is correlated with malnutrition leading to an unpreferable clinical course for pancreatic cancer patients underg… Co-author DOI 10.1007/s00595-019-01866-x↗
  4. PD-L1 expression enhancement by infiltrating macrophage-derived tumor necrosis factor-α leads to poor pancreatic cancer prognosis. Co-author DOI 10.1111/cas.13874↗
  5. Clinical usefulness of postoperative C-reactive protein/albumin ratio in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.amjsurg.2017.08.016↗
  6. Serum Marker Score Based on Prognostic Nutrition Index, Carcinoembryonic Antigen, and Carbohydrate Antigen 19-9 Is Associated With Recurrence for Patients Unde… Co-author DOI 10.1097/mpa.0000000000001146↗
  7. Thoracic wall muscle metastasis from pancreatic cancer. Co-author DOI 10.1186/s40792-017-0393-0↗
  8. Cystic gastric metastasis from pancreatic cancer. Co-author DOI 10.1186/s40792-018-0443-2↗

Closest collaborators

The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hirohisa Okabe · 5 shared papers, 2018–2026 · strength 0.63
  2. Shigeki Nakagawa · 6 shared papers, 2018–2021 · strength 0.49
  3. Akira Chikamoto · 6 shared papers, 2018–2020 · strength 0.47
  4. Katsunori Imai · 5 shared papers, 2018–2021 · strength 0.43
  5. Tatsunori Miyata · 5 shared papers, 2018–2021 · strength 0.42
  6. Takanobu Yamao · 5 shared papers, 2018–2020 · strength 0.39
  7. Hidetoshi Nitta · 2 shared papers, 2018–2026 · strength 0.38
  8. Masahiko Hirota · 2 shared papers, 2019–2026 · strength 0.38
  9. Hideo Baba · 4 shared papers, 2018–2021 · strength 0.36
  10. Masayo Tsukamoto · 4 shared papers, 2018–2020 · strength 0.31
  11. Kota Arima · 4 shared papers, 2018–2020 · strength 0.31
  12. Yuki Kitano · 4 shared papers, 2018–2020 · strength 0.31
  13. Daisuke Hashimoto · 4 shared papers, 2018 · strength 0.30
  14. Hiroki Sugita · 1 shared paper, 2026 · strength 0.30
  15. Toshiro Masuda · 1 shared paper, 2026 · strength 0.30
  16. Kensuke Yamamura · 3 shared papers, 2018 · strength 0.23
  17. Yosuke Nakao · 2 shared papers, 2020–2021 · strength 0.20
  18. Hiromitsu Hayashi · 2 shared papers, 2020–2021 · strength 0.20
  19. Rumi Itoyama · 2 shared papers, 2020–2021 · strength 0.20
  20. Hirohisa Okabe · 2 shared papers, 2018–2020 · strength 0.17
  21. Takatsugu Ishimoto · 2 shared papers, 2018–2019 · strength 0.14
  22. Hideo Baba · 2 shared papers, 2018 · strength 0.14
  23. Kenji Shimizu · 1 shared paper, 2018 · strength 0.09
  24. Hideo Baba · 1 shared paper, 2018 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.